MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.urology.2022.08.064

Медицинская библиотека · Urology · 2022

Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma.

Subiela José Daniel, González-Padilla Daniel A, Huguet Jorge, Aumatell Júlia, Rodríguez-Faba Oscar, Krajewski Wojciech, Feliu Alejandro Hevia, Mínguez Cesar, Plaza José López, Artiles Medina Alberto, Gajate Pablo, Jiménez Cidre Miguel Ángel, Burgos Revilla Javier, Breda Alberto, Palou Joan

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To assess clinical outcomes of patients who underwent simultaneous radical cystectomy (RC) and radical nephroureterectomy (RNU) for panurothelial carcinoma (PanUC).

MATERIALS AND

METHODS

A retrospective analysis of 67 patients who underwent simultaneous RC and unilateral RNU for PanUC, from 1996 to 2017. Kaplan-Meier estimates for remnant urothelium recurrence-free survival, metastasis-free survival, overall survival (OS), and cancer-specific survival (CSS) were performed. Cox multivariate models were constructed.

RESULTS

The median follow-up was 38 months, 29.8% of patients had a recurrence, 34.3% had metastasis, 67.2% of patients died from any cause, and 37.3% died from urothelial carcinoma. Overall survival and CSS rates at 5 years were 44% and 61%, respectively. In multivariate analysis, progression to muscle-invasive bladder cancer before surgery, presence of muscle-invasive stages at RC and/or RNU, and prostatic urethra involvement were predictors for worse metastasis-free survival and CSS. Forty-one patients (61.2%) had an estimated glomerular filtration rate (eGFR) <60 mL/min before surgery and the number rose to 56 (83.5%) after surgery; 29.8% patients needed renal function replacement therapy after surgery (16 haemodialysis and 4 renal transplant).

CONCLUSION

Patients with PanUC who undergo simultaneous surgery have adverse oncological (only 4 out of every 10 remain alive at 5 years) and functional outcomes (1 out of 3 will need renal function replacement therapy after surgery). Up to a third of the patients had a recurrence (urethra or contralateral kidney) within 18 months, justifying close surveillance or considering prophylactic urethrectomy. These data should help in counsel on morbidity and life expectancy.

Для цитирования: Subiela José Daniel, González-Padilla Daniel A, Huguet Jorge, Aumatell Júlia, Rodríguez-Faba Oscar, Krajewski Wojciech, Feliu Alejandro Hevia, Mínguez Cesar, Plaza José López, Artiles Medina Alberto, Gajate Pablo, Jiménez Cidre Miguel Ángel, Burgos Revilla Javier, Breda Alberto, Palou Joan. Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma.. Urology. 2022. DOI: 10.1016/j.urology.2022.08.064.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.